CPT® Code 86665 is used to report laboratory testing for Epstein-Barr virus (EBV) viral capsid antigen (VCA) antibodies. This test detects the presence of IgM and/or IgG antibodies to EBV VCA, which can help diagnose acute or past EBV infection. EBV is the virus responsible for infectious mononucleosis (“mono”) and is associated with other conditions such as certain lymphomas or chronic fatigue. Testing for VCA antibodies provides important diagnostic and clinical management information.
Key Facts About CPT® 86665
Service type: Serologic laboratory test
Provider type: Physicians and qualified healthcare professionals
Medical services included: Yes, detection of EBV VCA antibodies
Specimen type: Serum or plasma
Test method: Immunoassay (ELISA, immunofluorescence, or other validated methods)
Common clinical indications:
- Diagnosis of acute or recent EBV infection (infectious mononucleosis)
- Evaluation of past EBV exposure in patients with compatible symptoms
- Assessment of EBV status prior to immunosuppressive therapy or transplantation
- Investigation of unexplained fatigue, fever, lymphadenopathy, or pharyngitis
- Supporting diagnosis of EBV-associated malignancies in select cases
When to Use CPT® 86665
CPT 86665 is appropriate when:
- Laboratory testing for EBV VCA antibodies is medically necessary
- The test helps distinguish acute versus past EBV infection
- Results guide diagnosis, clinical management, or treatment decisions
- The specimen is properly collected and processed according to laboratory standards
Examples:
- A patient presenting with fever, sore throat, and lymphadenopathy undergoes EBV VCA antibody testing to confirm infectious mononucleosis
- Evaluating EBV exposure status in a patient with persistent fatigue
- Supporting the diagnosis of EBV-associated complications in immunocompromised patients
- Screening for past EBV infection prior to organ transplantation
Documentation Requirements
To support CPT 86665 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for EBV testing
- Specimen type and collection date
- Test method and results (IgM and/or IgG VCA antibodies)
- Interpretation of findings (acute vs. past infection)
- Ordering provider credentials and signature
- Laboratory performing the test
Thorough documentation ensures compliance, supports reimbursement, and facilitates clinical decision-making.
Reimbursement and Coding Considerations
- CPT 86665 is reimbursed when medically necessary and properly documented
- Coverage may vary based on payer policies and clinical indications
- Often ordered with other EBV antibody tests (e.g., EBNA, early antigen) to differentiate acute vs. past infection
- Proper diagnosis coding should support suspected EBV infection, infectious mononucleosis, or relevant clinical symptoms
- Verify payer-specific serology testing policies
Accurate coding and documentation help ensure appropriate reimbursement and reduce claim denials.
How OptiMantra Supports EBV VCA Antibody Testing
OptiMantra’s integrated EMR and practice management system streamlines ordering, documentation, and billing for CPT 86665:
With OptiMantra, providers can:
- Order EBV VCA antibody testing directly from the patient chart
- Document clinical indication, symptoms, and relevant patient history
- Review and track lab results over time within the patient’s longitudinal record
- Link lab findings to care plans, treatment decisions, and follow-up
- Support compliant, audit-ready billing codes for EBV serology testing
By centralizing laboratory workflows, OptiMantra helps practices improve efficiency, maintain compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
